Close

SAGE Therapeutics (SAGE), Biogen (BIIB) to Submit NDA for Zuranolone to FDA in Second Half of 2022 with Rolling Submission Expected to Start in Early 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SPY
5. INFY
6. SNV
7. TSLA
8. SMCI
9. SLB
10. PPG


Go back to SAGE Therapeutics (SAGE), Biogen (BIIB) to Submit NDA for Zuranolone to FDA in Second Half of 2022 with Rolling Submission Expected to Start in Early 2022
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 194.38 +3.86 (2.03%)
Previous Close $190.52    52 Week High $333.65 
Open $190.72    52 Week Low $223.02 
Day High $194.53    P/E 24.89 
Day Low $189.44    EPS $7.81 
Volume 1,599,576       

Sagebrush Gold Ltd. (NASDAQ: SAGE) Delayed: 13.33 +0.29 (2.22%)
Previous Close $13.04    52 Week High $62.64 
Open $12.93    52 Week Low $26.28 
Day High $13.61    P/E N/A 
Day Low $12.93    EPS $-0.94 
Volume 1,258,725